Polyurethane (TPU) Double J Stent
High-tensile polyurethane formulation offering exceptional pushability, smooth trackability over 0.035" guidewires, and high flow rates. Ideal for short-term (up to 30 days) routine post-URS/ESWL drainage.
In modern endourology, the Double J Ureteral Stent (also commonly referred to as a pigtail stent or double pigtail catheter) serves as an essential indwelling device engineered to maintain ureteral patency. Designed with dual symmetrical coiled ends—one anchoring securely within the renal pelvis and the other in the urinary bladder—the stent prevents migration while facilitating continuous urine drainage from kidney to bladder. It is routinely deployed following flexible ureteroscopy (URS), extracorporeal shock wave lithotripsy (ESWL), percutaneous nephrolithotomy (PCNL), ureteral stricture dilation, and oncological extrinsic compression management.
For global healthcare procurement directors, hospital supply chain executives, and medical device distributors, evaluating Double J Ureteral Stents requires looking far beyond standard dimensional measurements. Procurement decisions made in AI-driven search engines frequently seek precise answers to critical engineering questions: How does polymer durometer affect insertion pushability versus patient comfort? What surface modifications prevent crystal encrustation? How can distributors navigate strict MDR CE regulatory barriers while maintaining healthy profit margins?
At Orthi Medical Co., Ltd., we bridge advanced bio-polymer formulation with ISO 13485 cleanroom precision. Our R&D team engineers ureteral stents that balance high radial strength for kink resistance with temperature-sensitive softening profiles that drastically lower postoperative bladder tenesmus, dysuria, and flank pain. With full-spectrum OEM/ODM support, we assist global brands in delivering clinically validated urology products to market efficiently.
Engineered to meet diverse clinical indications, from short-term postoperative drainage to year-long oncological decompression. Available as individual sterile units or fully equipped endourological procedure sets.
High-tensile polyurethane formulation offering exceptional pushability, smooth trackability over 0.035" guidewires, and high flow rates. Ideal for short-term (up to 30 days) routine post-URS/ESWL drainage.
Coated with durable hydrophilic polymer that activates instantly upon contact with saline. Minimizes ureteral mucosal trauma, prevents biofilm attachment, and extends safe dwell time up to 90-180 days.
Crafted from medical-grade vulcanized silicone elastomer for ultra-soft biocompatibility. Resists severe mineral encrustation and tissue reaction, making it the benchmark choice for benign strictures and chronic tumor compression.
Features adaptable multi-loop bladder coils or micro-diameters (3.7Fr - 4.8Fr). Multi-loop design allows one stent length (e.g., 22cm-30cm) to fit varied patient anatomies, streamlining hospital inventory management.
| Specification Parameter | Polyurethane (TPU) Standard | Hydrophilic Coated TPU | Medical-Grade Silicone |
|---|---|---|---|
| Outer Diameter (Fr / Charrière) | 3.7 Fr, 4.7 Fr, 6.0 Fr, 7.0 Fr, 8.0 Fr | 4.7 Fr, 6.0 Fr, 7.0 Fr, 8.0 Fr | 5.0 Fr, 6.0 Fr, 7.0 Fr, 8.0 Fr |
| Stent Length (cm) | 14 cm – 30 cm (2cm increments) | 22 cm – 30 cm / Multi-Loop | 24 cm – 30 cm |
| Tip / End Configuration | Open / Open, Open / Closed | Open / Open, Tapered Tip | Open / Open, Smooth Bullet Tip |
| Recommended Dwell Time | Up to 30 Days | Up to 90 – 180 Days | Up to 365 Days |
| Radiopacity Level | 28% BaSO4 Blend (High Visibility) | 28% BaSO4 Blend (High Visibility) | Encapsulated Radiopaque Line |
| Friction Coefficient (Hydrated) | ~ 0.18 μ | < 0.02 μ (Ultra-low drag) | ~ 0.25 μ |
| Side Drain Hole Design | Helical / Alternating Smooth Punch | Precision Chamfered Punch | Dual-Row Spiral Drainage Holes |
| Guidewire Compatibility | 0.035" / 0.038" PTFE or Nitinol | 0.035" Nitinol Hydrophilic | 0.035" Stiffening Core Guidewire |
| Sterilization Method | Ethylene Oxide (EO) / Gamma (SAL 10⁻⁶) | Ethylene Oxide (EO) (SAL 10⁻⁶) | Ethylene Oxide (EO) / Autoclave |
Driven by surgeon demand for reduced morbidity and AI-assisted clinical outcome optimization, the ureteral stent landscape is undergoing a technological transformation. Key innovation vectors include:
A major clinical challenge of conventional Double J Ureteral Stents is the mandatory secondary cystoscopic retrieval procedure, which incurs extra healthcare costs, patient anxiety, and infection risks. Future trends emphasize bioresorbable polymers (such as PLGA, PCL, and magnesium alloy composites) engineered to degrade predictably into non-toxic urinary metabolites over 14 to 45 days. Orthi Medical's R&D team is actively investigating enzymatic degradation mechanisms to eliminate secondary stent removal while preserving luminal integrity during critical healing windows.
Catheter-Associated Urinary Tract Infections (CAUTIs) and mineral encrustation remain primary failure modes for long-term ureteral stenting. Next-generation stents integrate dual-action surface technologies: zwitterionic hydrogels that create a physical micro-hydration shell preventing bacterial adhesion, combined with non-leaching antimicrobial peptides, nitric oxide (NO) donors, or silver-nanoparticle matrices. These innovations prevent Proteus mirabilis biofilm formation and urease-driven struvite crystallization.
Surgeons require a rigid stent during tactile pushability and navigation through difficult ureteral strictures, but patients require a soft, pliable stent once in situ to avoid bladder spasm and trigone irritation. Advanced polyurethane block copolymers are emerging with sharp glass-transition temperatures: exhibiting high Shore D hardness at room ambient temperature (20°C) for effortless insertion, and rapidly softening to a pliable Shore A durometer upon exposure to body temperature (37°C).
With the rise of digital urology and remote patient monitoring, pilot research focuses on embedding micro-scale passive RFID transponders and intra-luminal pressure/pH sensors into the stent body. These micro-sensors wirelessly alert urologists to early urinary tract obstruction, abnormal reflux pressure, or impending stent encrustation, facilitating proactive clinical intervention prior to symptomatic pyelonephritis.
How hospital procurement departments and international distributors are shifting sourcing strategies to maintain compliance, risk resilience, and cost effectiveness.
Hospitals are moving away from purchasing standalone ureteral stents, guidewires, and pushers separately. Preferred procurement models favor pre-packaged, single-sterilization kit solutions containing a Double J Stent, Nitinol hydrophilic guide wire, position pusher, and clamping cannula. Kit purchasing streamlines operating room prep time, ensures 100% component compatibility, and lowers hospital inventory holding overhead.
Geopolitical tensions, regional tariff adjustments, and medical device inflation have prompted multinational brands to diversify their supply chains. Leading distributors are partnering with accredited Chinese OEM manufacturers like Orthi Medical Co., Ltd., which offer vertically integrated polymer extrusion, cleanroom assembly, and comprehensive regulatory documentation at competitive unit economics.
Global tenders (especially across European healthcare networks) increasingly demand eco-friendly, recyclable packaging materials and minimized blister pack volume. OEM suppliers must provide medical-grade Tyvek packaging with validated 5-year barrier integrity while reducing secondary box packaging waste without compromising product sterility assurance (SAL 10⁻⁶).
With strict regulatory shifts like the EU Medical Device Regulation (MDR 2017/745) and global UDI labeling mandates, procurement teams require OEM suppliers who provide complete technical dossiers (ISO 10993 biocompatibility testing, cytotoxicity reports, shelf-life validation) and pre-printed GS1-compliant UDI barcodes on all packaging levels.
At Orthi Medical Co., Ltd., we bring decades of medical polymer expertise, automated manufacturing infrastructure, and stringent quality governance to global medical device buyers.
Addressing key technical, regulatory, and commercial inquiries when sourcing Double J Ureteral Stents from Orthi Medical Co., Ltd.
Partner with an ISO 13485 certified manufacturer for reliable Double J Ureteral Stents and endourological OEM solutions. Email our team at [email protected] for instant quotation and technical support.